BACKGROUND: There are limited data assessing bronchodilator responsiveness (BDR) in infants and toddlers with recurrent wheezing, and factors associated with a positive response. OBJECTIVES: In a multicenter study of children ≤ 36 months old, we assessed the prevalence of and factors associated with BDR among infants/toddlers with recurrent episodes of wheezing. METHODS: Forced expiratory flows and volumes using the raised-volume rapid thoracic compression method were measured in 76 infants/toddlers [mean (SD) age 16.8 (7.6) months] with recurrent wheezing before and after administration of albuterol. Prior history of hospitalization or emergency department treatment for wheezing, use of inhaled or systemic corticosteroids, physician treatment of eczema, environmental tobacco smoke exposure, and family history of asthma or allergic rhinitis were ascertained. RESULTS: Using the published upper limit of normal for post bronchodilator change (FEV(0.5) ≥ 13% and/or FEF(25-75) ≥ 24%) in healthy infants, 24% (n = 18) of children in our study exhibited BDR. The BDR response was not associated with any clinical factor other than body size. Dichotomizing subjects into responders (defined by published limits of normal) or by quartile to identify children with the greatest change from baseline (4th quartile vs. other) did not identify any other factor associated with BDR. CONCLUSIONS: Approximately one quarter of infants/toddlers with recurrent wheezing exhibited BDR at their clinical baseline. However, BDR in wheezy infants/toddlers was not associated with established clinical asthma risk factors.
BACKGROUND: There are limited data assessing bronchodilator responsiveness (BDR) in infants and toddlers with recurrent wheezing, and factors associated with a positive response. OBJECTIVES: In a multicenter study of children ≤ 36 months old, we assessed the prevalence of and factors associated with BDR among infants/toddlers with recurrent episodes of wheezing. METHODS: Forced expiratory flows and volumes using the raised-volume rapid thoracic compression method were measured in 76 infants/toddlers [mean (SD) age 16.8 (7.6) months] with recurrent wheezing before and after administration of albuterol. Prior history of hospitalization or emergency department treatment for wheezing, use of inhaled or systemic corticosteroids, physician treatment of eczema, environmental tobacco smoke exposure, and family history of asthma or allergic rhinitis were ascertained. RESULTS: Using the published upper limit of normal for post bronchodilator change (FEV(0.5) ≥ 13% and/or FEF(25-75) ≥ 24%) in healthy infants, 24% (n = 18) of children in our study exhibited BDR. The BDR response was not associated with any clinical factor other than body size. Dichotomizing subjects into responders (defined by published limits of normal) or by quartile to identify children with the greatest change from baseline (4th quartile vs. other) did not identify any other factor associated with BDR. CONCLUSIONS: Approximately one quarter of infants/toddlers with recurrent wheezing exhibited BDR at their clinical baseline. However, BDR in wheezy infants/toddlers was not associated with established clinical asthma risk factors.
Authors: Frank D Gilliland; Kiros Berhane; Yu-Fen Li; Edward B Rappaport; John M Peters Journal: Am J Respir Crit Care Med Date: 2002-12-12 Impact factor: 21.405
Authors: A B Goldstein; R G Castile; S D Davis; D A Filbrun; R L Flucke; K S McCoy; R S Tepper Journal: Am J Respir Crit Care Med Date: 2001-08-01 Impact factor: 21.405
Authors: Stefan Zielen; Martin Christmann; Magdalena Kloska; Gülben Dogan-Yildiz; Adrian Lieb; Martin Rosewich; Ralf Schubert; Markus A Rose; Johannes Schulze Journal: Curr Med Res Opin Date: 2010-02 Impact factor: 2.580
Authors: Stefano Guerra; I Carla Lohman; Marilyn Halonen; Fernando D Martinez; Anne L Wright Journal: Am J Respir Crit Care Med Date: 2003-10-02 Impact factor: 21.405
Authors: Karen M McDowell; Alan H Jobe; Matthew Fenchel; William D Hardie; Tate Gisslen; Lisa R Young; Claire A Chougnet; Stephanie D Davis; Suhas G Kallapur Journal: Ann Am Thorac Soc Date: 2016-06
Authors: Nicholas J Nassikas; Elizabeth A W Chan; Christopher G Nolte; Henry A Roman; Niamh Micklewhite; Patrick L Kinney; E Jane Carter; Neal L Fann Journal: Air Qual Atmos Health Date: 2022-01-10 Impact factor: 3.763
Authors: Jean Bousquet; James E Gern; Fernando D Martinez; Josep M Anto; Christine C Johnson; Patrick G Holt; Robert F Lemanske; Peter N Le Souëf; Robert S Tepper; Erika R M von Mutius; S Hasan Arshad; Leonard B Bacharier; Allan Becker; Kathleen Belanger; Anna Bergström; David I Bernstein; Michael D Cabana; Kecia N Carroll; Mario Castro; Philip J Cooper; Matthew W Gillman; Diane R Gold; John Henderson; Joachim Heinrich; Soo-Jong Hong; Daniel J Jackson; Thomas Keil; Anita L Kozyrskyj; Karin C Lødrup Carlsen; Rachel L Miller; Isabelle Momas; Wayne J Morgan; Patricia Noel; Dennis R Ownby; Mariona Pinart; Patrick H Ryan; Julie M Schwaninger; Malcolm R Sears; Angela Simpson; Henriette A Smit; Debra A Stern; Padmaja Subbarao; Rudolf Valenta; Xiaobin Wang; Scott T Weiss; Robert Wood; Anne L Wright; Rosalind J Wright; Alkis Togias; Peter J Gergen Journal: J Allergy Clin Immunol Date: 2014-03-15 Impact factor: 10.793
Authors: Gyaviira Nkurunungi; Lawrence Lubyayi; Serge A Versteeg; Richard E Sanya; Jacent Nassuuna; Joyce Kabagenyi; Prossy N Kabuubi; Josephine Tumusiime; Christopher Zziwa; Robert Kizindo; Emmanuel Niwagaba; Carol Nanyunja; Margaret Nampijja; Harriet Mpairwe; Maria Yazdanbakhsh; Ronald van Ree; Emily L Webb; Alison M Elliott Journal: Clin Exp Allergy Date: 2019-01-25 Impact factor: 5.018